AGIO: Agios Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 1,636.39
Enterprise Value ($M) 1,548.19
Book Value ($M) 811.02
Book Value / Share 14.43
Price / Book 2.02
NCAV ($M) 707.74
NCAV / Share 12.59
Price / NCAV 2.31

Profitability (mra)
Return on Invested Capital (ROIC) -0.40
Return on Assets (ROA) -0.28
Return on Equity (ROE) -0.32

Liquidity (mrq)
Quick Ratio 11.99
Current Ratio 12.27

Balance Sheet (mrq) ($M)
Current Assets 833.84
Assets 937.12
Liabilities 126.10
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 26.82
Operating Income -391.49
Net Income -352.09
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -296.06
Cash from Investing 239.57
Cash from Financing 5.43

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G/A Rock Springs Capital Management LP 3.85 -28.18
02-14 13G/A Armistice Capital, Llc 6.31 28.15
02-13 13G/A Bb Biotech Ag 7.20 -0.76
02-12 13G/A Vanguard Group Inc 9.89 3.61
02-08 13G/A Farallon Capital Partners, L.P. 7.50 5.20
01-25 13G/A BlackRock Inc. 8.90 4.05
01-22 13G/A State Street Corp 4.70 -17.41
11-09 13G/A Wellington Management Group Llp 3.95 -61.55

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-15 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K
2023-11-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q
2023-08-03 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q
2023-05-04 10-Q Form 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-03-28 77,904 287,427 27.10
2024-03-27 118,870 543,369 21.88
2024-03-26 107,369 408,010 26.32
2024-03-25 59,349 413,837 14.34

(click for more detail)

Similar Companies
ACRS – Aclaris Therapeutics, Inc. ACT – Enact Holdings, Inc.
ADPT – Adaptive Biotechnologies Corporation AKRO – Akero Therapeutics, Inc.
ALEC – Alector, Inc.


Financial data and stock pages provided by
Fintel.io